5-FU/leucovorin: biochemical modulation that works?
Three cooperative groups are currently accruing patients to randomized Phase III studies of 5-FU plus leucovorin. These studies should provide data allowing more definitive conclusions regarding the therapeutic utility of this combination. Until results of these studies are available, 5-FU plus leucovorin (CF) remains an investigational treatment, not suitable for routine use.